SCHEMBL18780724

SCHEMBL18780724

CCCCCCCCCCCCCCCCOCCOCCCCC(C)=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 5/20 0.64
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
THRB P10828 1/20 0.57
HTT P42858 1/20 0.57
MAPT P10636 1/20 0.57
DGKA P23743 1/20 0.50
CES1 P23141 3/20 0.48
GPR84 Q9NQS5 6/20 0.46
PPARG P37231 6/20 0.46
PPARD Q03181 6/20 0.46
PPARA Q07869 6/20 0.46
HDAC11 Q96DB2 5/20 0.46
TSHR P16473 4/20 0.46
ALDH1A1 P00352 2/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
PTPN1 P18031 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17946903 0.98 CES2 (0.67) CES2MEN1KMT2ATHRBHTT
SCHEMBL31607440 0.98 CES2 (0.67) CES2MEN1KMT2ATHRBHTT
Water SCHEMBL5181823 0.96 CES2 (0.64) CES2MEN1KMT2ATHRBHTT
SCHEMBL28601607 0.96 CES2 (0.63) CES2MEN1KMT2ATHRBHTT
SCHEMBL2847742 0.94 CES2 (0.67) CES2MEN1KMT2ATHRBHTT
SCHEMBL16090840 0.94 CES2 (0.67) CES2MEN1KMT2ATHRBHTT
SCHEMBL28347220 0.94 CES2 (0.67) CES2MEN1KMT2ATHRBHTT
SCHEMBL10136280 0.94 CES2 (0.67) CES2MEN1KMT2ATHRBHTT
SCHEMBL16510217 0.94 CES2 (0.61) CES2MEN1KMT2ATHRBHTT
SCHEMBL704555 0.94 CES2 (0.61) CES2MEN1KMT2ATHRBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212662-A1 DEVELOPMENT OF NOVEL DETERGENTS FOR USE IN PCR SYSTEMS Life Technologies Corporation 2023-07-06 US disclosed
US-20170114391-A1 POLYMERIZATION OF NUCLEIC ACIDS USING PROTEINS HAVING LOW ISOELECTRIC POINTS Life Technologies Corporation 2017-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212662-A1 DEVELOPMENT OF NOVEL DETERGENTS FOR USE IN PCR SYSTEMS POLRMT, ABHD16A, PLD3 CES2 221/4885MEN1 4469/4885KMT2A 4410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.